City
Epaper

Estonia receives first batch of AstraZeneca COVID-19 vaccine

By ANI | Updated: February 7, 2021 20:10 IST

Estonia has received the first batch of the coronavirus vaccine developed by the UK-Swedish AstraZeneca pharmaceutical company along with Oxford University, the Estonian Ministry of Social Affairs said on Sunday.

Open in App

Estonia has received the first batch of the coronavirus vaccine developed by the UK-Swedish AstraZeneca pharmaceutical company along with Oxford University, the Estonian Ministry of Social Affairs said on Sunday.

Estonia has so far secured 3.5 million doses of coronavirus vaccines from five developers -- Pfizer/BioNTech, Moderna, AstraZeneca, Janssen Pharmaceutica NV and CureVac.

"The first batch of AstraZeneca's coronavirus vaccine including 7,200 doses arrived in Estonia on Sunday. In February, a total of 40,500 doses will be delivered to Estonia," the ministry said in a statement.

The vaccine is designed for people under 70 years old and those who work on the frontline in the fields of education, internal security, as well as social sphere, the ministry added.

Last week, the European Union's regulator authorized the AstraZeneca/Oxford vaccine for all age groups. However, given the lack of data on its efficacy in people aged over 55, a number of EU nations recommended its use only for those under 55 or 65 years old.

Estonia has launched its mass vaccination campaign in late December. To date, 35,905 people have been inoculated with the Pfizer/BioNtech and Moderna vaccines, with 17,512 of them having received both shots. (/Sputnik)

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Oxford UniversityAstrazenecaAstrazeneca plc.
Open in App

Related Stories

BusinessCelebrating Gandhi Jayanti: A Call to Wellness by Amravati's Bhupendra Goud at Oxford University

HealthDCGI Orders Withdrawal of AstraZeneca’s Anti-Cancer Drug Olaparib for Certain Treatments

HealthAfter Covishield, BHU Study Reveals Side Effects of Covaxin; Including Hair Loss, Skin Issues, and Menstrual Irregularities

InternationalAstraZeneca Withdraws COVID-19 Vaccine Globally Days After Side Effect Row, Firm Says Decision ‘Commercial’

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

International Realted Stories

InternationalLynched for belief: The systemic persecution of Ahmadi Muslims in Pakistan (IANS Analysis)

InternationalNine killed after man drives SUV into Canada street festival

InternationalBYC leaders enter third day of hunger strike amid media silence; Bebarg Baloch's health critically worsens

InternationalSouth Korea: Lee Jae-myung tapped presidential candidate for Democratic Party

InternationalUS military considering permanent deployment of F-35 fighter jets to South Korea: Report